CDA | Evidence Driven
CDA | Evidence Driven
News

Antihemophilic Factor (Recombinant BDD) Fc Fusion Protein (Eloctate): Treatment Cost Comparison and Budget Impact Analysis

The final science report is now available for the CADTH project on Antihemophilic Factor (Recombinant BDD) Fc Fusion Protein (Eloctate): Treatment Cost Comparison and Budget Impact Analysis.

Last Updated : November 9, 2015